Konan Receives the Europe's CE Mark for RAPDx® Pupil Diagnostic Device

Share Article

Konan Medical USA's new RAPDx high definition pupillograph has received Europe's CE Mark and sales will begin in Europe and other countries recognizing the CE Mark beginning at the largest European Ophthalmic congress, the ESCRS, in Milan, Italy.

The Konan RAPDx high definition pupillograph

The Konan RAPDx high definition pupillograph

Konan is pleased to add a new segment to our diagnostic imaging portfolio for Ophthalmology and Optometry.

Konan Medical USA, Inc. has announced that its RAPDx® pupillograph for screening of defects in pupil function has received the European CE Mark. The CE Mark identifies that the RAPDx device has met the EU’s health and safety standards and the company will begin shipping product to Europe and other countries recognizing the CE Mark in conjunction with the September 2012 ESCRS meeting in Milan, Italy.

“We are pleased to be able to start offering our new RAPDx pupil diagnostic product to our European customers,” said Charles Wm. Stewart, OD, CEO of Konan Medical USA. “With inquiries from every major European market, RAPDx is being acknowledged as filling an important niche for physicians by enhancing the assessment of pupillary defects, one of the only components of routine eye examinations that has never received a technological enhancement.”

“Konan is pleased to add a new segment to our diagnostic imaging portfolio for Ophthalmology and Optometry,” said Tetsuji Ikegami, Chairman of Konan Medical USA and CEO of Konan Inc. (Japan). “There is specific interest in this product for screening in the Japanese and other Asian markets.” Dale Sadlik, COO added, “the addition of CE Mark to our recent Japanese approval continues to add opportunity to our commercialization strategy.”

About Pupil Defects
The pupil light reflex is an objective indicator of specific function from the retina and optic nerve. A normal reflex, comparing left and right eyes is symmetric, however asymmetry (“RAPD” or “Relative Afferent Pupillary Defect”) can be a useful method to detect asymmetric diseases of the retina or optic nerve.

About Konan Medical USA, Inc.
Konan Medical USA is a privately held company based in Irvine, California specializing in diagnostic imaging products primarily for the eye care professions. Konan is the US market leader in specular microscopy both for clinical and eye banking uses. Konan Medical USA is a mostly owned subsidiary of Konan Medical Inc., a 60 year old precision optics and metrology company based in Hyogo, Japan. Konan Medical has over 1900 issued patents and has developed important core technologies for many aspects of the ophthalmic market. The Konan companies globally develop, sell, support, and service their innovative ophthalmic diagnostic products.
For more information, visit http://www.Konan-USA.com, http://konan.com, http://www.RAPDx.com or contact: Konan Medical USA, Inc., Dale Sadlik +1 (949) 521-7748 or dsadlik(at)konan-usa(dot)com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Dale Sadlik
Konan Medical USA, Inc.
+1 (949) 521-7730 7748
Email >
Visit website